NCT04267913 2020-11-20Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)SWOG Cancer Research NetworkPhase 2 Withdrawn